TP53 and breast cancer: The development of a PT and the coexistence of breast cancer inside the PT have both been linked to genetic alterations with intratumoral heterogeneity.[12] This transition of epithelial and mesenchymal components may be triggered by a variety of factors, including a mutation in the p53 gene.